We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Laura Elizabeth Lansdowne

Laura Elizabeth Lansdowne

Managing Editor

 at Technology Networks


As managing editor, Laura works with the associate editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She oversees the in-house editorial team and works directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.


Got a question for Laura Elizabeth Lansdowne?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 398
Challenges in ELN Adoption content piece image
Infographic

Challenges in ELN Adoption

This infographic aims to summarize the advantages and challenges associated with adopting Electronic Laboratory Notebooks (ELNs).
Researchers Discover a Promising Drug Target for Bowel Cancer content piece image
Article

Researchers Discover a Promising Drug Target for Bowel Cancer

The identification of this target is particularly exciting as it is unique to tumour cells, meaning that it is less toxic compared to existing therapies.
Exploring the Drug Discovery and Development Pipeline content piece image
Infographic

Exploring the Drug Discovery and Development Pipeline

Drug discovery and development can take up to 15 years and cost over $1 billion dollars. This infographic details the steps involved from conceptualization of a treatment to bringing it to market.
Umbilical Cord-Derived Stem Cells Could Help Those with Heart Failure content piece image
Article

Umbilical Cord-Derived Stem Cells Could Help Those with Heart Failure

Umbilical cord-derived stem cells could be the answer for patients with heart failure. A study published yesterday, indicates that cardiac muscle function and quality-of-life could be enhanced after treatment with this specific type of stem cell.
Encouraging Step Towards a Potential Therapeutic Strategy for Asthma content piece image
Article

Encouraging Step Towards a Potential Therapeutic Strategy for Asthma

Researchers have discovered a compound with the ability to induce long-lasting bronchorelaxation and prevent hyperreactivity in murine models of asthma.
Could a Lipid be the Key to Treating Chronic Inflammatory Diseases? content piece image
Article

Could a Lipid be the Key to Treating Chronic Inflammatory Diseases?

The lipid, 10-nitro-oleic-acid, an endogenous nitro-fatty acid (NFA) modulator, is being explored as a treatment for chronic inflammatory diseases. Prof. Valerie O'Donnell's group was one of the few that originally identified the lipid’s ability to reduce inflammation.
LipidFinder: An Open-Source Python Workflow for Novel Lipid Discovery content piece image
Article

LipidFinder: An Open-Source Python Workflow for Novel Lipid Discovery

Researchers at the University of Cardiff, UK have developed a Python based computational workflow that is tailored to the analysis of large volumes of data, with the ability to identify novel lipids.
Cell-based Imaging and Screening Applications content piece image
Industry Insight

Cell-based Imaging and Screening Applications

BioStatus develops and supplies products for cell-based imaging, cytometry and screening applications. We met with Roy Edward, Director at BioStatus during the High Content and Phenotypic Screening 2017 event to learn more.
Advertisement